Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer

Autor: Jian Hu, Zhaohui Fan, Qi-Xun Chen, Yi Zhang, Qingchen Wu, Satoshi Watanabe, Yang Liu, Jiaqing Xiang, Hecheng Li, Junqiang Fan, Hao Zhang, Junji Uchino, Wen-Xiang Wang, Xiao-Jie Pan, Haitao Ma, Hui Tian, Ben G. L. Vanneste, Nai-Quan Mao, Toyoaki Hida, Yun-Chao Huang, Takeo Nakada, Bin Qiu, Dirk De Ruysscher, Qiang Li, Kaican Cai, Hao Long, Qingquan Luo, Jie Jiang, Hongxu Liu, Wei-Dong Hu, Stefano Bongiolatti, Shinji Sasada, Tao Jiang, Chun Chen, Raffaele Califano, Fengwei Tan, Jie He, Peng Zhang, Lunxu Liu, Jun Chen, Nobuhiko Seki, Kenneth W. Merrell, Jun-Feng Liu, Zhenfa Zhang, Federico Cappuzzo, Sai Yendamuri, Pierfilippo Crucitti, Haruhiko Sugimura, Paul Hofman, Nan Wu, Gening Jiang, Yongde Liao, Chao Cheng, Shugeng Gao, Julian R. Molina, Li Wei, Lijie Tan, Giulio Metro, In-Jae Oh, Yusuke Tomita, Wenjie Jiao, Yuming Zhu, William C. Cho, Stefania Rizzo, Lanjun Zhang, Mariano Provencio, Sang-Won Um, Jessica C. Sieren, Ke-Neng Chen, Said Dermime, Dong Wang, Shidong Xu, Lin Yang, Kunshou Zhu, Tian-Yang Dai, Kye Young Lee, Filippo Longo, Muhammad Furqan
Přispěvatelé: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie
Rok vydání: 2021
Předmět:
Zdroj: Transl Lung Cancer Res
Translational Lung Cancer Research, 10(9), 3713-3736. AME Publishing Company
ISSN: 2218-6751
2226-4477
Popis: The treatment of lung cancer is one of the major challenges in the field of oncology. According to statistics from the National Cancer Center of China in 2015, lung cancer has the highest incidence and mortality, with 733,300 new cases and 610,200 deaths across the country (1). About 85% of lung cancers are non-small cell lung cancer (NSCLC), of which 30% to 40% are considered resectable tumors, including most stage I-II and a small portion of stage IIIA tumors (2). Very early-stage NSCLC (IA) can be cured by surgery. However, more than 50% of NSCLC patients who undergo surgical treatment will relapse or metastasize within 5 years. Even if there is no lymph node metastasis and the primary
Databáze: OpenAIRE